Metraipolis › archive › dc_61a433d58727

Concurrent icotinib and definitive radiotherapy followed by detection of an EGFR exon 20 insertion at disease progression in unresectable stage III EGFR… — Europe PMC PMID:42620773

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42620773
DOI
10.3389/fonc.2026.1902085
License (as archived)
solo-consultazione
Archived
2026-10-17T03:11:56.305Z
SHA-256 of the archived text
a3a4b3c19d02ac2936681e6d561bfa9709ee7e81def80aa1cfcebf15b57b306f
Stable URL of this page
https://metraipolis.com/documento/dc_61a433d58727

How to cite

Concurrent icotinib and definitive radiotherapy followed by detection of an EGFR exon 20 insertion at disease progression in unresectable stage III EGFR… — Europe PMC PMID:42620773 — Europe PMC (en), https://europepmc.org/article/MED/42620773 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_61a433d58727 (Metraipolis archive dc_61a433d58727, sha256 a3a4b3c19d02ac2936681e6d561bfa9709ee7e81def80aa1cfcebf15b57b306f)
BibTeX
@misc{dc61a433d58727,
  title = {Concurrent icotinib and definitive radiotherapy followed by detection of an EGFR exon 20 insertion at disease progression in unresectable stage III EGFR… — Europe PMC PMID:42620773},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42620773},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_61a433d58727; sha256 a3a4b3c19d02ac2936681e6d561bfa9709ee7e81def80aa1cfcebf15b57b306f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42620773. Agents can read the archived copy with the MCP tool read_document.